Khaliullin, F.A.,
Klen, E.E.,
Nikitina, I.L.,
Pavlov, V.N.,
Rozit, G.A.,
Gaisina, G.G.,
Samorodov, A.V. (2023) the duration of immobilization in the forced swimming
test by 44% as compared to the control group. Compound
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to
test the therapeutic effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used
Khaliullin, F. A.,
Klen, E. E.,
Nikitina, I. L.,
Pavlov, V. N.,
Rozit, G. A.,
Gaisina, G. G.,
Samorodov, A. V. (2023) the duration
of immobilization in the forced swimming
test by 44% as compared to the control group. Compound
Musin, I. I.,
Yashchuk, A.G.,
Pavlov, V.N.,
Wang, J.,
Sun, X.,
Naftulovich, R.A.,
Popova, E.M. (2022) using Miyazaki's technique. Conclusions: Considering the Food and
Drug Administration's 2019 decision
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) targeting JNK. In the present study, we have
tested the hypothesis that C66 could prevent obesity